1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with Parkinson Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Kajta, M; Michaluk, J; Romańska, I; Wąsik, A | 1 |
| Kotake, Y; Ohta, S; Okuda, K; Sekiya, Y | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Nalepa, I; Romańska, I; Wąsik, A; Zelek-Molik, A | 1 |
| Hiramatsu, T; Hirokane, Y; Hosoya, T; Ikeshoji, H; Kohta, R; Kotake, Y; Koyama, H; Ohta, S; Oofusa, K; Otsubo, Y; Suzuki, M; Yokoyama, Y | 1 |
| Kotake, Y | 1 |
| Deleu, D | 1 |
| Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
1 review(s) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Parkinson Disease
| Article | Year |
|---|---|
[Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
Topics: Animals; Brain; Catechol O-Methyltransferase; Cells, Cultured; Dopamine; Electron Transport Complex I; Humans; Isoquinolines; Mice; Mitochondria; NADH, NADPH Oxidoreductases; Neurotoxins; Parkinson Disease; Tetrahydroisoquinolines | 2002 |
6 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Parkinson Disease
| Article | Year |
|---|---|
1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.
Topics: Animals; Corpus Striatum; Dopamine; Hippocampus; Hyperkinesis; In Vitro Techniques; Levodopa; Male; Neurotoxins; Parkinson Disease; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Tetrahydroisoquinolines | 2014 |
Detection of a novel neurotoxic metabolite of Parkinson's disease-related neurotoxin, 1-benzyl-1,2,3,4- tetrahydroisoquinoline.
Topics: Animals; Blood-Brain Barrier; Chromatography, Liquid; Molecular Weight; Neuroblastoma; Neurotoxins; Parkinson Disease; Rats, Wistar; Tandem Mass Spectrometry; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2014 |
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Hyperkinesis; Male; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Tetrahydroisoquinolines | 2016 |
1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination.
Topics: Animals; Cell Line, Tumor; Down-Regulation; Humans; Mice; Neurotoxins; Parkinson Disease; Polyubiquitin; Protein Binding; Substrate Specificity; Tetrahydroisoquinolines; Tubulin; Ubiquitin-Protein Ligases; Ubiquitination | 2010 |
Endogenous dopamine-derived neurotoxins and Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Dopamine; Humans; Isoquinolines; Methyltransferases; MPTP Poisoning; Nerve Tissue Proteins; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Salsoline Alkaloids; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1998 |
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |